Artificial intelligence continues to reshape biotech and healthcare domains. Michigan State University researchers combined nanomedicine and AI to detect rare cancer biomarkers, improving early diagnosis of metastatic prostate cancer and atherosclerosis. Meanwhile, Intermountain Health invested in AI-powered clinical data abstraction technologies to enhance patient registries. At the same time, a study highlighted vulnerabilities in conversational AI chatbots that can propagate health misinformation, underscoring challenges in deploying AI safely within medical communication.